Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
Washington University School of Medicine
Washington University School of Medicine
Centre Oscar Lambret
Institut du Cancer de Montpellier - Val d'Aurelle
Duke University
St. Joseph's Hospital and Medical Center, Phoenix
Endeavor Biomedicines, Inc.
Eli Lilly and Company
Institute of Oncology Ljubljana
Servier
Servier
Blueprint Medicines Corporation
Reveal Pharmaceuticals Inc.
Hospices Civils de Lyon
Seattle Children's Hospital
Washington University School of Medicine
Stanford University
Milton S. Hershey Medical Center
Columbia University
Dana-Farber Cancer Institute
Mayo Clinic
Virginia Commonwealth University
Institut du Cancer de Montpellier - Val d'Aurelle
Hospices Civils de Lyon
Kintara Therapeutics, Inc.
Mayo Clinic
Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc.
Oblato, Inc.
LanZhou University
InSightec
Istari Oncology, Inc.
Hackensack Meridian Health
Mayo Clinic
Washington University School of Medicine
Alpheus Medical, Inc.
SonoClear AS
Cedars-Sinai Medical Center
The University of Hong Kong
BioMimetix JV, LLC
Central Hospital, Nancy, France
St. Joseph's Hospital and Medical Center, Phoenix
Washington University School of Medicine
Biogen
Thomas Jefferson University
Thomas Jefferson University
German Cancer Research Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)